Loading organizations...
Loading organizations...
Biotechnology company developing transformative gene therapeutics.
4D Molecular Therapeutics has raised $168.0M across 3 funding rounds.
4D Molecular Therapeutics has raised $168.0M in total across 3 funding rounds.
4D Molecular Therapeutics has raised $168.0M in total across 3 funding rounds.
4D Molecular Therapeutics's investors include Viking Global Investors, Amzak Health, ArrowMark Partners, Berkeley Catalyst Fund, BVF Partners, Casdin Capital, Chiesi Ventures, Michael Boyle, Longevity Vision Fund, Mirae Asset, Octagon Capital, Perceptive Advisors.
4D Molecular Therapeutics has raised $168.0M across 3 funding rounds. Most recently, it raised $75.0M Series C in June 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 16, 2020 | $75.0M Series C | Viking Global Investors | Amzak Health, ArrowMark Partners, Berkeley Catalyst Fund, BVF Partners, Casdin Capital, Chiesi Ventures, Michael Boyle, Longevity Vision Fund, Mirae Asset, Octagon Capital, Perceptive Advisors, QUAD Investment Management |
| Sep 5, 2018 | $90.0M Series B | Viking Global Investors | Tony Yao, Berkeley Catalyst Fund, BVF Partners, Chiesi Ventures, CureDuchenne Ventures, Janus Henderson Investors, Mirae Asset, Perceptive Advisors, Ridgeback Capital Investments |
| Sep 19, 2017 | $3.0M Other Equity | Cystic Fibrosis Foundation |